During Vienna Polyphenols World Congress, Dr Lynne Howells from University of Leicester will present the recent study concerning Curcumin in combination with chemotherapy.
According to Dr Howeels: "Combining low toxicity polyphenolic adjuncts with standard-of-care chemotherapy may offer added benefit to patients without increasing side effect burdens. Here, we have taken a bench to bedside approach, examining the effects of curcumin in combination with oxaliplatin-based therapy in colorectal cancer. Promising in vitro and pre-clinical data has led to the work-up of the CUFOX phase I/IIa trial, combining curcumin with FOLFOX-based chemotherapy in patients with metastatic colorectal cancer."
The results of this study will be presented during Vienna Polyphenols World Congress: www.polyphenols-site.com